Physician profile
David Heligman
NPI 1972504512
$732.89
in general payments reported to CMS, 2019-2025
17 companies · $47.57 in 2025
The $47.57 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $170 · 2021: $133 · 2022: $79.59 · 2024: $65.40 · 2025: $47.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $144.92 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $78.36 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $72.53 | 2024-2025 | Xtampza |
| Mallinckrodt Enterprises LLC | $62.57 | 2019 | |
| Amgen INC. | $57.95 | 2019-2020 | |
| Si-Bone, INC. | $55.26 | 2019 | |
| Ermi LLC | $46.81 | 2020-2021 | |
| Medtronic, INC. | $40.82 | 2022-2024 | Inceptiv |
| Ferring Pharmaceuticals INC. | $37.32 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $31.79 | 2019-2021 | |
| Orthogenrx INC. | $18.16 | 2019 | |
| Avanos Medical | $17.73 | 2024 | Grpro 2.1 |
| Orthofix Medical, INC. | $17.66 | 2019 | |
| Carbofix Orthopedics INC | $15.18 | 2019 | |
| Pfizer INC. | $14.59 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $12.11 | 2019 | |
| Fidia Pharma USA INC. | $9.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Heligman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.